ORMD-0801 clinical trials
Also written ORMD-0801.
How each study uses ORMD-0801 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the ORMD-0801 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 2
Oramed, Ltd. (8) · Hadassah Medical Organization (1) · King Hamad University Hospital, Bahrain (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test ORMD-0801, phase 3 first.
- Apr 2027A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus.Phase 3 · Oramed, Ltd.
Studies
Open first, then newest update. How each study uses ORMD-0801 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 10
- A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus.Not yet recruitingPhase 3Oramed, Ltd.NCT06731075Written as ORMD-0801 8 mg
- A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)CompletedPhase 2Oramed, Ltd.NCT04618744Written as ORMD-0801 (Insulin) capsule 8 mg BD
- A Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes MellitusCompletedPhase 2Oramed, Ltd.NCT04564846Written as ORMD-0801
- A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes MellitusTerminatedPhase 3Oramed, Ltd.NCT04754334Written as ORMD-0801
- A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes MellitusCompletedPhase 2Oramed, Ltd.NCT03467932Written as Cohort A: ORMD-0801
- Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes MellitusStatus unknownPhase 3King Hamad University Hospital, BahrainNCT04817215Written as ORMD-0801
- Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes MellitusCompletedPhase 2Oramed, Ltd.NCT02496000Written as ORMD-0801
- A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes MellitusCompletedPhase 2Oramed, Ltd.NCT02954601Written as ORMD-0801 (qd)
- A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 DiabeticsCompletedPhase 2Oramed, Ltd.NCT02094534Written as ORMD-0801 Capsules
- Effectiveness of Oral Insulin in Unstable Type 1 Diabetes PatientsCompletedPhase 2Hadassah Medical OrganizationNCT00867594Written as ORMD 0801